These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. Malempati RN; Bond DJ; Yatham LN Int Clin Psychopharmacol; 2008 Mar; 23(2):88-94. PubMed ID: 18301123 [TBL] [Abstract][Full Text] [Related]
5. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994 [TBL] [Abstract][Full Text] [Related]
6. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder. MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785 [TBL] [Abstract][Full Text] [Related]
7. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone. Vieta E; Nieto E; Autet A; Rosa AR; Goikolea JM; Cruz N; Bonet P World J Biol Psychiatry; 2008; 9(3):219-24. PubMed ID: 18609430 [TBL] [Abstract][Full Text] [Related]
8. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness. Keith S Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665 [TBL] [Abstract][Full Text] [Related]
9. Risperidone liquid treatment of acute mania. Abraham TM Can J Psychiatry; 2003 Jul; 48(6):425. PubMed ID: 12894618 [No Abstract] [Full Text] [Related]
10. [Risperidone use in child and adolescent psychiatric patients]. Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D Therapie; 2008; 63(5):359-75. PubMed ID: 19154706 [TBL] [Abstract][Full Text] [Related]
11. Risperidone monotherapy in manic inpatients: an open label, multicentre trial. Forsthoff A; Grunze H; Seemüller F; Stampfer R; Dittmann S; Amann B; Schmidt F; Schäfer M; Hermle L; Walden J; Schreiner A World J Biol Psychiatry; 2007; 8(4):256-61. PubMed ID: 17853251 [TBL] [Abstract][Full Text] [Related]
12. Trial of risperidone in India--concerns. Srinivasan S; Pai SA; Bhan A; Jesani A; Thomas G Br J Psychiatry; 2006 May; 188():489; author reply 490-1; discussion 491-2. PubMed ID: 16648542 [No Abstract] [Full Text] [Related]
13. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Han C; Lee MS; Pae CU; Ko YH; Patkar AA; Jung IK Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1219-23. PubMed ID: 17532106 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities. Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032 [No Abstract] [Full Text] [Related]
17. [Use of Hunperdal Richter in psychiatry]. Magyar GI; Fadgyas I Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319 [TBL] [Abstract][Full Text] [Related]
18. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder. Gianfrancesco FD; Sajatovic M; Tafesse E; Wang RH Ann Clin Psychiatry; 2009; 21(1):3-16. PubMed ID: 19239828 [TBL] [Abstract][Full Text] [Related]